PubMed=18772397; DOI=10.1126/science.1164368; PMCID=PMC2848990
Jones S., Zhang X.-S., Parsons D.W., Lin J.C.-H., Leary R.J., Angenendt P., Mankoo P., Carter H., Kamiyama H., Jimeno A., Hong S.-M., Fu B.-J., Lin M.-T., Calhoun E.S., Kamiyama M., Walter K., Nikolskaya T., Nikolsky Y., Hartigan J., Smith D.R., Hidalgo M., Leach S.D., Klein A.P., Jaffee E.M., Goggins M.G., Maitra A., Iacobuzio-Donahue C.A., Eshleman J.R., Kern S.E., Hruban R.H., Karchin R., Papadopoulos N., Parmigiani G., Vogelstein B., Velculescu V.E., Kinzler K.W.
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
Science 321:1801-1806(2008)

PubMed=22753594; DOI=10.1158/1078-0432.CCR-12-0827; PMCID=PMC3513499
Cui Y.-F., Brosnan-Cashman J.A., Blackford A.L., Sur S., Hruban R.H., Kinzler K.W., Vogelstein B., Maitra A., Diaz L.A. Jr., Iacobuzio-Donahue C.A., Eshleman J.R.
Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity.
Clin. Cancer Res. 18:6519-6530(2012)